Home > List All Publishers > CBR Pharma Insights, LLC

CBR Pharma Insights, LLC

The mission of CBR Pharma Insights is to empower companies within the pharmaceutical industry to make the best business decisions possible through providing them with quality, innovative, strategic market research solutions.

CBR’s market research solutions are focused on being both proactive & reactive in identifying, evaluating, and assessing the key strategic R&D and commercial issues within the pharmaceutical industry.

List of reports from CBR Pharma Insights, LLC

The Payer Landscape in the United States – The Pharmaceutical Industry Faces a Rapidly Changing Marketplace 3/1/2012 \| published by: CBR Pharma Insights, LLC ... 2010 providing changes for both. That said, private payers, such as regionals, nationals and blues plans, may take the brunt of the reform policies put in place. The health care reform legislation in 2010 was ... \| more... Search inside this report	$3,900.00
The Next Generation of Pharmaceutical Marketing Strategies – Understanding All of the Strategic Considerations Needed in the Age of Multiple Stakeholders 3/1/2012 \| published by: CBR Pharma Insights, LLC ... a period of great transformation. Lacking a crystal ball, the industry as a whole is navigating through unchartered waters. Multiple factors are driving the need for industry-wide change. One of the biggest contributors is the ... \| more... Search inside this report	$3,900.00
Pharmaceutical Pricing Strategies – Changing Approaches to Meet Challenging Times 3/1/2012 \| published by: CBR Pharma Insights, LLC ... discounts forced upon them and new drugs being subject to increasingly complex assessments in order to obtain the desired price. Novel pricing policies, such as value based pricing and external price referencing, are being employed ... \| more... Search inside this report	$3,900.00
Reformulation Strategies – New Technologies Extend Use Beyond Lifecycle Management 1/1/2012 \| published by: CBR Pharma Insights, LLC ... new technologies emerge compliment its position as a key lifecycle management strategy. Reformulation will continue to be a much used lifecycle management strategy, enabling companies to boost sales before patent expiry and in ideal cases ... \| more... Search inside this report	$3,900.00
Looking at Senior Long-term Care - Where Will the Market Go? P 12/1/2011 \| published by: CBR Pharma Insights, LLC ... Skilled Nursing. Memory Care facilities, for those with Alzheimer’s Disease or Dementia are often separate facilities, but may be part of a larger CCRC campus. Long-term care is becoming increasingly important as a market with ... \| more... Search inside this report	$3,900.00
The Impact of Generics on Pharmaceutical Growth Opportunities - A growing threat that offers future opportunities 10/1/2011 \| published by: CBR Pharma Insights, LLC ... this, pharma is experiencing a wave of blockbuster patent expiries, with almost $30 billion in US sales (at 2010 levels) exposed by the largest 10 drugs which are expected to experience generic competition for the ... \| more... Search inside this report	$3,900.00
Risk Evaluation and Mitigation Strategies - Adaptation in an Evolving System 10/1/2011 \| published by: CBR Pharma Insights, LLC ... (REMS) program in 2008. Products can be approved with a Medication Guide only REMS, a Communication Plan REMS - which incorporates a Medication Guide together with educational materials for providers or it can require Elements ... \| more... Search inside this report	$3,900.00
Accelerating Drugs to Market - In Search of Opportunity Along the Drug Development & Approval Pathway 9/1/2011 \| published by: CBR Pharma Insights, LLC ... gain competitive advantages and to start recouping development costs. From product concept to market, there are a number of potential areas of opportunity for accelerating a drug through to FDA approval. Many initiatives tie to ... \| more... Search inside this report	$3,900.00
Pharmaceutical Sales Force Effectiveness - Rethinking the Current Sales Model 8/1/2011 \| published by: CBR Pharma Insights, LLC ... to this mix Health Care Reform and the way a company develops, markets, and sells their products is impacted on some level. The next 5 - 10 years will be an exciting time to be ... \| more... Search inside this report	$3,900.00
Pharmaceutical Cliff Diving - Assessing the Key Challenges that will Re-Shape the Industry 7/1/2011 \| published by: CBR Pharma Insights, LLC ... big pharma, sales were flat to negative for most, but a number of companies found that their work to streamline and restructure were showing positive results, with Q1 profits up. The industry faces challenges from ... \| more...	$3,900.00
The Coming Age of Biosimilars - Regulatory Developments and Alliance Strategies Intensify Interest in a Developing Market 5/1/2011 \| published by: CBR Pharma Insights, LLC ... predicting it will grow to the multi-billion dollar level within five years, while others point to the limited impact of biosimilars in Europe to date to suggest that it will never be a major threat ... \| more...	$3,900.00
New Product Launch Strategies - Initiating Market Entry with Sound Strategies and Tactics 4/1/2011 \| published by: CBR Pharma Insights, LLC ... growth; however lost opportunities at the entry of a product to a market can necessitate re- launch and re-branding activities which can be costly and cumbersome. Additionally, these “Plan B” tactics are not always effective. ... \| more...	$3,900.00
The Impact of Economic Factors on the Pharmaceutical Industry - Where the Next Five Years Will Take Us 3/1/2011 \| published by: CBR Pharma Insights, LLC ... we’re currently in has brought a number of challenges for the pharmaceutical industry, such as loss of health coverage through unemployment, decreasing health benefits for those still employed, and a lessened ability to pay for ... \| more...	$3,900.00
Pharmaceutical and Biotech Licensing Strategies - Driving Revenue through Partnerships 1/1/2011 \| published by: CBR Pharma Insights, LLC ... one grounded in collaboration. Companies are no longer relying solely on their own internal R&D programs for innovation; they are looking outside of their four walls. Some have labeled this ‘search and development’. There are ... \| more...	$3,900.00
Managed Care and the Pharmaceutical Industry - Top Issues, Health Care Reform, and the Inter-linkages Bringing them Together 12/1/2010 \| published by: CBR Pharma Insights, LLC ... of their brand-name drugs. Common ground between the two industries can be difficult to find. Shared goals do exist, though. Both the managed care industry and the pharmaceutical industry have a stake in how prescription ... \| more...	$3,900.00
Personalized Medicine - Opening Doors and Overcoming Challenges 11/1/2010 \| published by: CBR Pharma Insights, LLC ... has begun to change as more personalized medicines have been developed outside of the oncology field. The spread of personalized medicine to other fields has increased the challenge of physician uptake, with many GPs not ... \| more...	$3,900.00
The Perception of the Pharmaceutical Industry - What the Web is Saying about Health Care Reform, Safety, and Drug Costs 10/1/2010 \| published by: CBR Pharma Insights, LLC ... with filling a prescription. Even though the industry will be contributing approximately $80 billion in fees and rebates towards the recent US health care reform legislation, the consumers’ perception is that they have actually contributed ... \| more...	$3,900.00
The Aging Population - How and Where to Succeed with the Over 50 Crowd 9/1/2010 \| published by: CBR Pharma Insights, LLC ... total population. By 2050, this figure is estimated to grow to 20% - increasing the burden placed on society. Today’s Seniors are happy, active, and living in the communities of their choice. This independence, which ... \| more...	$3,900.00
Social Media and e-Communication within the Pharmaceutical Industry - Understanding the Future of Direct-to-Consumer Marketing 8/1/2010 \| published by: CBR Pharma Insights, LLC ... and Facebook, disease-specific communities, blogs, and other social internet applications, the opportunities for sharing information have increased at a significant pace. Today, three-fourths of American adults use the internet regularly and four-fifths of American adult ... \| more...	$3,900.00
The New Era of Healthcare Reform - Supporting Revenue Growth through Understanding and Adaptation 6/1/2010 \| published by: CBR Pharma Insights, LLC ... role in legislation implementation to ensure those benefits are realized. Through the new laws, there are both wins and losses for the pharmaceutical industry, such as changes effecting Medicare/Medicaid, health insurance coverage expansion & protection, ... \| more...	$3,900.00
Emerging Market Strategies - Mapping the Opportunities for Pharmaceutical Expansion 4/1/2010 \| published by: CBR Pharma Insights, LLC ... to drive future product sales and overall company revenues. The different situations which exist within each emerging market offer a wide variety of opportunities along with their own set of accompanying challenges. In order to ... \| more...	$3,900.00
Optimizing Pipeline Performance - Maximizing Future Sales Opportunities through Pipeline Optimization and Benchmarking Strategies 3/1/2010 \| published by: CBR Pharma Insights, LLC ... being seen with new drug approvals, having an efficient R&D process is crucial to a company’s future success. This report assesses the key issues impacting pharmaceutical product development, while providing insight & analysis into the ... \| more...	$3,900.00
The Economy and the Pharmaceutical Industry - Adherence to Drug Treatments and How the Current Economic Environment is Affecting Patients’ Treatment Choices 11/1/2009 \| published by: CBR Pharma Insights, LLC ... also lose their ability to cover the costs of healthcare, including prescription drugs. Being un-or under-insured drives consumers to seek out ways to save money on medical costs, or in some cases to skip medical ... \| more...	$3,900.00
Pharmaceutical Mergers and Acquisitions - M&A in the Biopharmaceutical Industry and the Impact on Innovation 9/1/2009 \| published by: CBR Pharma Insights, LLC ... Warner-Lambert by Pfizer in 2000, to the recent acquisition of Wyeth, pharmaceutical and biotech companies have expanded their pipelines, portfolios, and sales forces through mergers and acquisitions (M&A). Mergers and Acquisitions have defined the landscape ... \| more...	$3,900.00
Lifecycle Management Strategies - Key Tools to Maximize Return on Investment in a Tough Healthcare Environment 9/1/2009 \| published by: CBR Pharma Insights, LLC ... strategies in order to maximize their portfolios sales over the long term. In an increasingly difficult operating environment, optimizing LCM strategies is an important way for companies to maximize their return on investment. However, the ... \| more...	$3,900.00